FindTrial
Sign In

Study on Immunoinflammatory Characteristics in Heart Failure Patients Based on Cardiac Tissue and Peripheral Blood

Study on Immunoinflammatory Characteristics in Heart Failure Patients Based on Cardiac Tissue and Peripheral Blood

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600116085
Enrollment
Unknown
Registered
2026-01-05
Start date
2026-01-05
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ischemic Cardiomyopathy

Interventions

ICM patient group:None
DCM patient group:None
Control group:None

Sponsors

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.DCM/ICM patients who met the criteria for and received heart transplantation; 2.Age>=18 years, gender is not limited; 3.Sign the informed consent form;

Exclusion criteria

Exclusion criteria: 1.Abnormal renal function (creatinine clearance 3 × the upper limit of normal); 3.Uncontrolled infectious diseases; 4.Immunological or immune-related diseases, such as systemic lupus erythematosus, asthma, inflammatory bowel disease, gout, malignant tumors, etc. 5.Any other condition in which the investigator considers the patient unsuitable for participation in the clinical study;

Design outcomes

Primary

MeasureTime frame
Antibodies and inflammation-related proteins;—

Countries

China

Contacts

Public ContactCheng Xiang

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

nathancx@hust.edu.cn+86 27 85726685

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026